celecoxib has been researched along with propyphenazone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dalby, KN; Kaoud, TS; Radwan, MF | 1 |
| Conde, J; Delgado, J; Florido, JF; López-Pascual, E; Nieto, MA; Ortega, N; Quiralte, J; Sáenz de San Pedro, B | 1 |
1 trial(s) available for celecoxib and propyphenazone
| Article | Year |
|---|---|
Safety of the new selective cyclooxygenase type 2 inhibitors rofecoxib and celecoxib in patients with anaphylactoid reactions to nonsteroidal anti-inflammatory drugs.
Topics: Adult; Aged; Anaphylaxis; Anti-Inflammatory Agents, Non-Steroidal; Antipyrine; Celecoxib; Cyclooxygenase Inhibitors; Dipyrone; Drug Hypersensitivity; Female; Humans; Lactones; Male; Middle Aged; Prospective Studies; Pyrazoles; Single-Blind Method; Sulfonamides; Sulfones | 2004 |
1 other study(ies) available for celecoxib and propyphenazone
| Article | Year |
|---|---|
Propyphenazone-based analogues as prodrugs and selective cyclooxygenase-2 inhibitors.
Topics: | 2014 |